Assignee
KALIVIR IMMUNOTHERAPEUTICS INC
US·7 granted patents·10 pending applications·0 citations·filing 2018–2025
Top patents by PatentIndex Score
17 records- 0181US11963990B2Oncolytic viruses for modified MHC expressionKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2023·Granted Apr 23, 2024·0 cites·19 claims
- 0281US2024277793A1Oncolytic viruses for modified mhc expressionKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0381US2024277794A1Oncolytic viruses for modified mhc expressionKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0480US12016893B2Oncolytic viruses for modified MHC expressionKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2022·Granted Jun 25, 2024·0 cites·24 claims
- 0579US2025041368A1Oncolytic Immunotherapy by Tumor Micro-Environment RemodelingKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0679US2025009824A1Oncolytic Immunotherapy by Tumor Micro-Environment RemodelingKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0778US12403165B2Oncolytic immunotherapy by tumor micro-environment remodelingKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2023·Granted Sep 2, 2025·0 cites·27 claims
- 0875US12472217B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2022·Granted Nov 18, 2025·0 cites·22 claims
- 0974US12318419B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2021·Granted Jun 3, 2025·0 cites·15 claims
- 1074US12226440B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2021·Granted Feb 18, 2025·0 cites·18 claims
- 1168US12036257B2Platform oncolytic vector for systemic deliveryKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2018·Granted Jul 16, 2024·0 cites·29 claims
- 1263US2025249054A1Methods of Treating CancerKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1361US2022031777A1Methods of Treating CancerKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1456US2022220505A1Producer Viruses for Generation of Retroviruses In SituKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1556US2025064873A1TNFSF-L Fusion Proteins and Uses ThereofKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1653US2022049228A1Modified Extracellular Enveloped VirusKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1751US2025302899A1Compositions of cd47/sirp-alpha immune checkpoint inhibitors and uses thereofKALIVIR IMMUNOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →